Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine for CINV Prevention in Multi-day Chemotherapy (OFFER)
NCT04536558Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT04536558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04536558.